- Home
- ALRN vs MGLD Comparison
ALRN vs MGLD Comparison
Compare ALRN & MGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALRN
- MGLD
- Stock Information
- Founded
- ALRN 2001
- MGLD 1996
- Country
- ALRN United States
- MGLD United States
- Employees
- ALRN N/A
- MGLD N/A
- Industry
- ALRN Biotechnology: Pharmaceutical Preparations
- MGLD Finance/Investors Services
- Sector
- ALRN Health Care
- MGLD Finance
- Exchange
- ALRN Nasdaq
- MGLD Nasdaq
- Market Cap
- ALRN 76.9M
- MGLD 80.3M
- IPO Year
- ALRN 2017
- MGLD N/A
- Fundamental
- Price
- ALRN $1.97
- MGLD $1.71
- Analyst Decision
- ALRN Strong Buy
- MGLD
- Analyst Count
- ALRN 1
- MGLD 0
- Target Price
- ALRN $19.00
- MGLD N/A
- AVG Volume (30 Days)
- ALRN 137.2K
- MGLD 24.6K
- Earning Date
- ALRN 11-14-2024
- MGLD 02-12-2025
- Dividend Yield
- ALRN N/A
- MGLD N/A
- EPS Growth
- ALRN N/A
- MGLD N/A
- EPS
- ALRN N/A
- MGLD N/A
- Revenue
- ALRN N/A
- MGLD $32,511,000.00
- Revenue This Year
- ALRN N/A
- MGLD N/A
- Revenue Next Year
- ALRN N/A
- MGLD N/A
- P/E Ratio
- ALRN N/A
- MGLD N/A
- Revenue Growth
- ALRN N/A
- MGLD N/A
- 52 Week Low
- ALRN $1.61
- MGLD $0.78
- 52 Week High
- ALRN $7.42
- MGLD $2.10
- Technical
- Relative Strength Index (RSI)
- ALRN 41.44
- MGLD 51.19
- Support Level
- ALRN $1.90
- MGLD $1.64
- Resistance Level
- ALRN $2.17
- MGLD $1.99
- Average True Range (ATR)
- ALRN 0.18
- MGLD 0.20
- MACD
- ALRN 0.02
- MGLD -0.02
- Stochastic Oscillator
- ALRN 23.27
- MGLD 23.68
About ALRN Aileron Therapeutics Inc.
Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. The company currently has two product candidates in clinical development, LTI-03 and LTI-01, and multiple candidates in preclinical development focused on fibrosis indications.
About MGLD The Marygold Companies Inc.
The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.